Therefore, we obtained tissues of cervical cancer patients from the hospital, and it was found that CXCL10, GZMB and CD8A were increased in patients sensitive to the efficacy of immunotherapy, suggesting that CXCL10, GZMB and CD8A may be potential therapeutic targets for cervical cancer immunotherapy. The gene discussed is CD8A; the disease is cervical carcinoma.